Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shunda Du

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Clinical and Molecular Hepatology|May 29, 2024
Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical settingXueshuai Wan, Karin Wisskirchen, Tao Jin, et al.
BMC Cancer|October 10, 2020
Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumorLejia Sun, Xin Ji, Dongyue Wang, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|July 30, 2021
Subharmonic Scattering of SonoVue Microbubbles Within 10-40-mmHg Overpressures In VitroGang Xu, Huimin Lu, Huayu Yang, et al.
Journal of Nanobiotechnology|December 18, 2025
Three-dimensional bioprinting of patient-derived Gastrointestinal stromal tumor: a novel platform for precision oncology and drug response profilingLiwei Du, Zicheng Zheng, Yanan Wang, et al.
Cancer Management and Research|October 3, 2022
In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic CholangiocarcinomaJiayi Li, Qiao Chen, Lei Guo, et al.
Current Cancer Drug Targets|September 22, 2020
Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic CholangiocarcinomaYingyi Wang, Bao Jin, Na Zhou, et al.
Molecular Cancer|October 15, 2025
Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer modelsLiwei Du, Zicheng Zheng, Kai Zhang, et al.
The Journal of Surgical Research|August 22, 2025
The Age-Male-Albumin-Bilirubin-Platelet Risk Score Predicts Postoperative Prognosis of Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective StudyJia Yang, Gang Xu, Xi Xu, et al.
Neuroendocrinology|April 26, 2021
A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation StudyGang Xu, Yao Xiao, Hanjie Hu, et al.
Journal of Clinical Gastroenterology|March 15, 2016
Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From CholangiocarcinomaShunda Du, Gang Liu, Xinqi Cheng, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Clinical and Molecular Hepatology|May 29, 2024
Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical settingXueshuai Wan, Karin Wisskirchen, Tao Jin, et al.
BMC Cancer|October 10, 2020
Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumorLejia Sun, Xin Ji, Dongyue Wang, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|July 30, 2021
Subharmonic Scattering of SonoVue Microbubbles Within 10-40-mmHg Overpressures In VitroGang Xu, Huimin Lu, Huayu Yang, et al.
Journal of Nanobiotechnology|December 18, 2025
Three-dimensional bioprinting of patient-derived Gastrointestinal stromal tumor: a novel platform for precision oncology and drug response profilingLiwei Du, Zicheng Zheng, Yanan Wang, et al.
Cancer Management and Research|October 3, 2022
In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic CholangiocarcinomaJiayi Li, Qiao Chen, Lei Guo, et al.
Current Cancer Drug Targets|September 22, 2020
Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic CholangiocarcinomaYingyi Wang, Bao Jin, Na Zhou, et al.
Molecular Cancer|October 15, 2025
Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer modelsLiwei Du, Zicheng Zheng, Kai Zhang, et al.
The Journal of Surgical Research|August 22, 2025
The Age-Male-Albumin-Bilirubin-Platelet Risk Score Predicts Postoperative Prognosis of Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective StudyJia Yang, Gang Xu, Xi Xu, et al.
Neuroendocrinology|April 26, 2021
A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation StudyGang Xu, Yao Xiao, Hanjie Hu, et al.
Journal of Clinical Gastroenterology|March 15, 2016
Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From CholangiocarcinomaShunda Du, Gang Liu, Xinqi Cheng, et al.
Pageof 13